SEC Comment Letter for CANNA Corp (CIK 0001582962) — Mar 23, 2020
CANNA Corp (CIK 0001582962)
Date: March 23, 2020 · CIK: 0001582962 · Accession: 0000000000-20-002526
AI Filing Summary & Sentiment
File numbers found in text: 000-55788
Letter
March 23, 2020 Sacha Alessandro Ceruti Chief Executive Officer Canna Corp. 8358 West Oakland Park Blvd. Suite 300 Sunrise, Florida 33323 Re:Canna Corp. Current Report on Form 8-K Filed March 17, 2020 File No. 000-55788 Dear Mr. Ceruti: Our initial review of your filing indicates that it fails in numerous material respects to comply with the requirements of the Securities Exchange Act of 1934, the rules and regulations thereunder and the requirements of the form. More specifically: Please revise your current report on Form 8-K to provide the information required by Item 2.01(f) of Form 8-K and the related financial information required by Item 9.01 of Form 8-K for Agra Nutraceuticals Corporation. We will provide more detailed comments relating to your filing following our review of a substantive amendment that addresses these deficiencies. Please contact Sergio Chinos, Staff Attorney, at (202) 551-7844 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing
Show Raw Text
March 23, 2020
Sacha Alessandro Ceruti
Chief Executive Officer
Canna Corp.
8358 West Oakland Park Blvd.
Suite 300
Sunrise, Florida 33323
Re:Canna Corp.
Current Report on Form 8-K
Filed March 17, 2020
File No. 000-55788
Dear Mr. Ceruti:
Our initial review of your filing indicates that it fails in numerous material respects to
comply with the requirements of the Securities Exchange Act of 1934, the rules and regulations
thereunder and the requirements of the form. More specifically:
Please revise your current report on Form 8-K to provide the information required by Item
2.01(f) of Form 8-K and the related financial information required by Item 9.01 of Form
8-K for Agra Nutraceuticals Corporation.
We will provide more detailed comments relating to your filing following our review of a
substantive amendment that addresses these deficiencies.
Please contact Sergio Chinos, Staff Attorney, at (202) 551-7844 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing